Patent · US Expired

Cleavage system inhibitors as potential antipsychotics

US6395780B1 · kind B1 · utility

7Cited by

0References

4Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Michael Arlt · Seeheim-Jugenheim, DE
Gerd Bartoszyk · Weiterstadt, DE

Key dates

Filing date	Apr 28, 2000
Grant date	May 28, 2002
Priority date	—
Expiry date	Apr 28, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to inhibitors of the glycine cleavage system and their use as potential antipsychotic agents. The invention relates furthermore to a process for treating humans having psychosis, psychosis associated with an illness, schizophrenia, Alzheimers disease or other related psychotic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.